Featured
Ex-Aussie GM lands top new role
Less than three years after leaving Australia, this leader who spent five years heading the ANZ team has won another promotion
Industry & Companies
Aussie repurposer swaps shares for NZ start-up
The move gives access to a repurposed treatment for patients with multiple sclerosis, with the buy raising capital to fund the drug's trial
Industry & Companies
Top pharma employers as voted by staff
Twelve pharmas made the Top 20 science-focused companies to work for list, voted in by the people who work there. See who made the cut
Regulatory & Reimbursement
Action urged on 'dangerously under-recognised' disease
Boehringer has launched a report to increase public awareness and exhort government action on a disease that makes people feel their lungs are concrete
Pipeline & Intellectual Property
Cancer drug's 'unprecedented' trial results
Slashes the risk of death by 58% in this lung cancer patient cohort, with the company describing the findings as a watershed moment in the management of the disease
Government & Policy
Dept boasts faster medicines access
Annual Report hails 100 per cent strike rate on six-months-to-listing target but the fine print reveals the numbers don't tell the full story
Industry & Companies
Is pharma finally in a good mood?
The bright future pharma has been dreaming of has arrived... at least for some with positive sentiment on a steep climb - except when it comes to the prospect of finding a new job
Regulatory & Reimbursement
Four pharmas start run for Govt funding
A company navigating Australia's reimbursement system for the first time is kicking off the race for Government funding
Featured
Ex-BMS exec wins Aussie Country Lead role
After more than 15 years at BMS, this well-known executive has joined a Canadian company to lead its Australian operations
Industry & Companies
CSL grilled by many cooks
Shareholders turned up the heat at the company's AGM this morning, with the outgoing Chair conceding it had overpaid for an US$11.7B acquisition
Leadership & People
Company announces another leadership change
Long-time boss to be replaced next year by someone whose history with the organisation runs just as deep
Leadership & People
Pharma exec shares life lessons after horror bus crash
National Sales Manager Sharyn Junkeer shares the lessons she's painfully learned about life and career after suffering critical injuries in a horror bus crash
Featured
Farewells dominate Aussie pharma job moves
Departures from companies, Australia and even industry have dominated the latest round of job moves across pharma
Government & Policy
Butler talks security in the wake of Haines attack
Health Minister has not upped his security in the last week, but concedes changes likely need to be made
Industry & Companies
Astellas turns up the heat on politicians
Temperatures were high when three Sydney MPs visited the pharma's Macquarie Park office. Find out why
Regulatory & Reimbursement
PBAC-ticked gene therapy wins TGA nod
A new form of a gene therapy expands the indicated population to catch those who weren't diagnosed in time
Pipeline & Intellectual Property
Secret data leak, landmark results... then a share tumble
Over a tumultuous few hours, impressive data on the world's first mRNA cancer vaccine was leaked, then praised, before a tumble on the stock market
Awards
LinkedIn names Australia's best workplaces
Healthtech has emerged as a major force in this year’s LinkedIn Top Startups Australia list, an annual ranking of the emerging companies where professionals want to work
Pipeline & Intellectual Property
Aussies tapped for US gene project
UQ researchers selected to help the US produce personalised genetic therapies in hospitals to deliver RNA medicines to patients within days of diagnosis, instead of months
Government & Policy
Australia's long road to closing CAR T gap
Funding CAR T treatments isn't enough when structural barriers prevent the majority of referrals from accessing CAR T.
Popular
Pharma boss smashes two glass ceilings
Inducted into the Hall of Fame as a "pioneer of breaking glass ceilings" in both gender and age, this pharma leader has been honoured for her vision and courage
Jobs
Leadership & People
Ex-Aussie GM nabs top job with newcomer
This well-known boss is back in Australia and leading the region for a company that's chasing approvals globally for a drug that's been hailed a game-changer
Industry & Companies
Arrotex signs deal for locally-developed med
Agreement brings together innovative anti-infective development platform and the Aussie giant's established regulatory, market access and commercial capabilities
Jobs & Workplace
Feeling disengaged? Here's what might be missing
An industry survey has uncovered the most important motivator for workplace engagement with more than 2300 open-ended comments pointing to one must-have
Regulation & Legal
CSL slapped with investor class action
A lawsuit has been filed by investors who bought shares during a calamitous price plunge but CSL has promised to 'vigorously' defend all accusations
Latest
BioNTech opens Aussie mRNA facility
World-class facility in Melbourne will help deliver the next generation of life-changing treatments in cancer, heart disease, and neurological and autoinflammatory diseases
Leadership & People
CSL names ex-Aussie GM as new CEO
After a global search, CSL has picked a former Aussie GM and a 'world-class, purpose-driven' high-flyer from a rival pharma to be its fourth CEO
Patients
Aussie patient groups speak up on pricing
New website reveals that Australian patients are among the most active in the world when it comes to taking their case for medicines access to drug-pricing regulators
Industry & Companies
Aussie industry mega-event in full swing
Three flagship events brought together by AusBiotech for the first time is underway on the Gold Coast with more than 2500 expected to attend
Industry & Companies
Can doctors be bought for the price of a sandwich?
The more free meals a doctor receives from pharma, the more likely they are to prescribe less appropriate or more expensive drugs, according to a new review
- Industry & Companies Time-poor doctors move from papers to podcast
- Regulatory & Reimbursement 15 drugs jostle for November PBS listings
- Industry & Companies Takeover sends shares tumbling by 34%
- Industry & Companies Bots move in at pharma logistics base
- Government & Policy Trump splurges on Big Pharma shares
- Regulatory & Reimbursement PBAC tweaks November Agenda
- Regulatory & Reimbursement Rare disease drugs head for Australia
- Industry & Companies Roche stakes $22B bet on Chinese ADCs
- Industry & Companies Who's scored a seat on the Medicines Australia Board?
- Regulatory & Reimbursement Sept PBAC: Winners and Losers